Here's the live share price of Shilpa Medicare along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Shilpa Medicare has gained 4.58% CAGR. Over the past year, the corresponding return has been -33.04%.
Shilpa Medicare’s current P/E of 38.21x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Shilpa Medicare | -8.47 | -17.19 | -26.77 | -41.30 | -34.18 | 29.26 | 4.58 |
| Sun Pharmaceutical Industries | -2.08 | -6.88 | -3.23 | -2.86 | -10.89 | 15.91 | 23.23 |
| Divi's Laboratories | -2.45 | -6.07 | -7.32 | -8.60 | 4.01 | 21.56 | 11.40 |
| Torrent Pharmaceuticals | 0.28 | 5.52 | 11.41 | 13.39 | 23.38 | 36.16 | 24.53 |
| Cipla | -1.67 | -8.38 | -16.45 | -6.70 | -5.28 | 8.96 | 11.21 |
| Dr. Reddy's Laboratories | 3.54 | -5.13 | -4.90 | -2.44 | -5.60 | 11.94 | 3.87 |
| Lupin | -0.50 | 2.46 | 11.61 | 12.75 | 0.70 | 41.42 | 14.94 |
| Zydus Lifesciences | 1.85 | -4.77 | -12.30 | -8.15 | -10.61 | 25.81 | 13.94 |
| Mankind Pharma | -1.19 | -3.59 | -12.21 | -17.33 | -18.32 | 14.72 | 8.59 |
| Alkem Laboratories | -1.24 | 3.02 | 4.21 | 15.82 | 11.27 | 23.74 | 13.69 |
| Aurobindo Pharma | -2.44 | -6.01 | 4.07 | 2.39 | -8.16 | 36.90 | 4.37 |
| Biocon | -1.30 | -7.16 | 2.84 | -6.10 | -6.15 | 14.48 | -1.10 |
| Abbott India | -0.28 | -2.26 | -7.97 | -20.28 | -0.50 | 8.25 | 13.96 |
| Glenmark Pharmaceuticals | -0.23 | -2.48 | 7.90 | -6.67 | 31.97 | 68.30 | 32.15 |
| Laurus Labs | -6.63 | -5.93 | 7.28 | 22.21 | 71.80 | 42.37 | 22.08 |
| GlaxoSmithKline Pharmaceuticals | 1.80 | -4.30 | -13.36 | -23.62 | 14.28 | 23.23 | 9.51 |
| Ipca Laboratories | -1.54 | 3.66 | 16.64 | 1.62 | -6.09 | 19.42 | 7.75 |
| Anthem Biosciences | -1.71 | -9.58 | -15.77 | -19.89 | -17.16 | -6.08 | -3.70 |
| Ajanta Pharma | 1.18 | 1.70 | 12.23 | -0.18 | -6.11 | 31.33 | 18.77 |
| J B Chemicals & Pharmaceuticals | -0.11 | 5.30 | 11.28 | 12.46 | 5.23 | 24.44 | 30.77 |
Over the last one year, Shilpa Medicare has declined 34.18% compared to peers like Sun Pharmaceutical Industries (-10.89%), Divi's Laboratories (4.01%), Torrent Pharmaceuticals (23.38%). From a 5 year perspective, Shilpa Medicare has underperformed peers relative to Sun Pharmaceutical Industries (23.23%) and Divi's Laboratories (11.40%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 290.13 | 279.46 |
| 10 | 299.23 | 288.52 |
| 20 | 309.88 | 300.52 |
| 50 | 333.2 | 323.87 |
| 100 | 360.67 | 348.12 |
| 200 | 383.65 | 364.18 |
In the latest quarter, Shilpa Medicare saw a drop in promoter holding to 40.15%, while DII stake increased to 8.34%, FII holding rose to 10.97%, and public shareholding moved up to 40.56% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 24,97,968 | 0.42 | 80.22 | |
| 20,65,936 | 0.45 | 66.35 | |
| 19,26,298 | 0.96 | 61.86 | |
| 8,14,922 | 1.32 | 26.17 | |
| 4,86,964 | 1.87 | 15.64 | |
| 4,47,198 | 0.29 | 14.36 | |
| 2,92,082 | 0.21 | 9.38 | |
| 2,84,227 | 0.83 | 9.13 | |
| 2,05,542 | 0.47 | 6.6 | |
| 1,96,585 | 0.44 | 6.31 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jan 16, 2026, 6:31 PM IST | Shilpa Medicare L - Assignment Of ESG Rating By SES ESG Research Pvt Ltd |
| Jan 15, 2026, 3:26 PM IST | Shilpa Medicare L - Intimation Under Regulation 30 Of SEBI(LODR) Regulations, 2015 |
| Jan 06, 2026, 10:32 PM IST | Shilpa Medicare L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 30, 2025, 6:56 PM IST | Shilpa Medicare L - Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or |
| Dec 12, 2025, 5:15 PM IST | Shilpa Medicare L - Intimation Under Of Regulation 30 Of The SEBI(LODR) Regulations |
Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 477.34 Cr. and Equity Capital is Rs. 9.78 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shilpa Medicare is ₹268.10 as on Jan 22, 2026.
The Shilpa Medicare is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Shilpa Medicare is ₹5,243.55 Cr as on Jan 22, 2026.
Today’s highest and lowest price of Shilpa Medicare are ₹283.15 and ₹268.10.
The 52-week high/low is the highest and lowest price at which Shilpa Medicare stock has traded in the past 52-week or nearly a year. The 52-week high of Shilpa Medicare is ₹501.60 and 52-week low of Shilpa Medicare is ₹265.25 as on Jan 22, 2026.
The Shilpa Medicare has shown returns of -1.69% over the past day, -18.95% for the past month, -26.77% over 3 months, -33.04% over 1 year, 29.26% across 3 years, and 4.58% over 5 years.
P/E ratio of and PB ratio of Shilpa Medicare are 38.21 and 2.21 on Jan 22, 2026. While the company gives a dividend yield of 0.00 per annum.